表紙
市場調查報告書

全球基因學市場:市場規模,佔有率,趨勢分析 - 各用途、技術、零組件(設備、消耗品、服務)、終端用戶、地區 2018年∼2025年

Genomics Market Size, Share & Trends Analysis Report By Application And Technology (Pathway Analysis, Functional Genomics), By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2019 - 2025

出版商 Grand View Research, Inc. 商品編碼 666043
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球基因學市場:市場規模,佔有率,趨勢分析 - 各用途、技術、零組件(設備、消耗品、服務)、終端用戶、地區 2018年∼2025年 Genomics Market Size, Share & Trends Analysis Report By Application And Technology (Pathway Analysis, Functional Genomics), By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2019 - 2025
出版日期: 2019年06月21日內容資訊: 英文 120 Pages
簡介

全球基因學市場,預計至2025年成長到276億美元規模的市場。過去數十年,由於基因學及個人化醫療進步,對疾病管理流程出現很大的變化。

本報告提供全球基因學市場調查,市場概要,各零組件、終端用戶、地區的市場規模的變化與預測,成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述

第2章 調查方法

  • 資訊採購
  • 資訊分析
  • 市場結構、檢驗

第3章 市場變數、趨勢、範圍

  • 市場區隔和範圍
  • 滲透率與成長預測
  • SWOT分析
  • 波特的五力分析

第4章 基因學市場預測與趨勢分析:各零件

  • 市場趨勢分析:各零件
  • 產品
    • 設備/系統
    • 消耗品/試劑
  • 服務
    • 核心基因服務
    • NGS服務
    • 生物標記翻譯服務
    • 計算服務
    • 其他

第5章 基因學市場預測與趨勢分析:各用途

  • 市場趨勢分析:各用途
  • 功能的基因學
    • 轉染
    • 即時PCR
    • RNA干擾
    • 突然變異分析
    • SNP分析
    • 微陣列分析
  • 表觀基因
    • 亞硫酸氫鹽定序
    • 染色質免疫沉澱 - 定序(ChIP-Seq)
    • 甲基化DNA免疫沉澱(MeDIP)
    • 高解析度溶融
    • 染色絲可及性化驗
    • 微陣列分析
  • 途徑分析
    • 以微珠為基礎分析(Bio-Plex)
    • 微陣列分析
    • 即時PCR
    • 蛋白質體學工具
  • 生物標記探索
    • 質譜分析
    • 即時PCR
    • 微陣列分析
    • 統計分析
    • 生物資訊學
    • DNA定序
  • 其他

第6章 基因學市場預測與趨勢分析:各終端用戶

  • 市場趨勢分析:各終端用戶
  • 臨床機關、研究所
  • 學術機構、政府機關
  • 醫院、診療所
  • 製藥、生物科技企業
  • 其他

第7章 基因學市場預測與趨勢分析:各地區

  • 市場佔有率:各地區(成果值、預測值)
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭情形

  • 策略架構
  • 參與企業的分類
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-188-7

The global genomics market size is expected to reach USD 27.61 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.6% during the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the growing trend of targeted therapies.

Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and consumers. This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data.

Ability of the medical community to make use of the available genomic information in personalized medicine is anticipated to significantly impact the genomics market. Furthermore, plummeting cost of sequencing has enabled the whole genome sequencing at very less price. Scientists are combining the sequencing generated data with diagnostics which has proven its effectiveness in enhancing personalized treatment landscape.

The companies are involved in strategic alliances with global as well as local entities to boost their revenue generation and enhance their market share. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company, as a result of which Bristol-Myers Squibb could deploy Foundation Medicine's molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials.

NGS-based services held a major market share in the services segment due to its rapid adoption of whole genome sequencing and application of sequence databases for disease screening and prognosis. The demand would remain strong with the expansion of the customer base from limited to academic and research centers to CROs, biotech and pharma players. As patients are focusing on their health, Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. DTC genetic tests enable consumers to access information about their genetics without necessarily including healthcare professionals in the process.

Further key findings from the report suggest:

  • High demand in terms of volume coupled with the high cost of specific reagents contribute to substantial revenue share. Companies are embracing the trend of offering varied reagents that simplify workflow process
  • Use of predictive biomarkers for diagnosis and monitoring take cancer eradication a step further. Moreover, organizations and programs such as the National Biomarker Development Alliance (NBDA) are actively participating in development of novel biomarkers for cancer diagnosis
  • Growing interest of pharmaceutical and biotechnology companies in genomics is expected to drive growth of the genomics market in the forthcoming years
  • Asia Pacific is anticipated to display the maximum potential and an become an emerging market for genomics. It is anticipated to register the fastest CAGR of 10.4% over the forecast period

Major players include: BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc; Foundation Medicine, Inc, 23andMe, Inc, Danaher, Illumina, Inc; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.

Table of Contents

Chapter 1 Research methodology

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Genomics Market Outlook, 2014-2025

Chapter 3 Industry Outlook

  • 3.1 Penetration & Growth Prospects Mapping
  • 3.2 Trend analysis
    • 3.2.1 Application trends
    • 3.2.2 Product trends
    • 3.2.3 End use trends
    • 3.2.4 Regional trends
  • 3.3 Genomics - Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Growing integration of genomics data into clinical workflows
      • 3.3.1.1.1 More targeted and personalized healthcare
      • 3.3.1.1.2 Growth of newborn genetic screening programs
      • 3.3.1.1.3 Advancements in noninvasive cancer screening
      • 3.3.1.1.4 Military genomics
      • 3.3.1.2 Technological advances to facilitate genomic R&D
      • 3.3.1.2.1 Emergence of advanced genome editing techniques
      • 3.3.1.2.2 Integration of new data streams
      • 3.3.1.2.3 RNA biology
      • 3.3.1.2.4 Single cell biology
      • 3.3.1.3 Rising adoption of direct to consumer genomics
      • 3.3.1.4 Success of genetic tools in agrigenomics
      • 3.3.1.5 Increasing participation of different companies
      • 3.3.1.6 Increase in government role and funding in genomics
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Issues regarding intellectual property protection, data management, and public policies
      • 3.3.2.2 Dearth of skilled personnel
  • 3.4 Oppurtunity Analysis
  • 3.5 Industry Analysis - Porter's
    • 3.5.1 Supplier power - Medium
    • 3.5.2 Buyer power - High
    • 3.5.3 Substitution threat - Low
    • 3.5.4 New entrants threat - Low
  • 3.6 Regulatory landscape: Genomics- SWOT by PEST Analysis
    • 3.6.1 Political landscape
    • 3.6.2 Economic landscape
    • 3.6.3 Social landscape
    • 3.6.4 Technology landscape
  • 3.7 Company market share analysis
  • 3.8 Competitive landscape
    • 3.8.1 Strategy framework
    • 3.8.2 Company categorization
      • 3.8.2.1 New entrants
      • 3.8.2.2 Mature players & leaders

Chapter 4 Genomics Market Categorization: Deliverables Outlook

  • 4.1 Genomics Market Share By Deliverabales Outlook, 2014 To 2025
  • 4.2 Products Market, 2014 to 2025
    • 4.2.1 Products market revenue (USD Million), by North America
    • 4.2.2 Products market revenue (USD Million), by Europe
    • 4.2.3 Products market revenue (USD Million), by Asia Pacific
    • 4.2.4 Products market revenue (USD Million), by Latin America
    • 4.2.5 Products market revenue (USD Million), by Middle-East & Africa
    • 4.2.6 Instruments/Systems market, 2014 to 2025, USD million
      • 4.2.6.1 Instruments/Systems market revenue (USD Million), by North America
      • 4.2.6.2 Instruments/Systems market revenue (USD Million), by Europe
      • 4.2.6.3 Instruments/Systems market revenue (USD Million), by Asia Pacific
      • 4.2.6.4 Instruments/Systems market revenue (USD Million), by Latin America
      • 4.2.6.5 Instruments/Systems market revenue (USD Million), by Middle-East & Africa
    • 4.2.7 Consumables/ Reagents, 2014 to 2025, USD million
      • 4.2.7.1 Consumables/ Reagents market revenue (USD Million), by North America
      • 4.2.7.2 Consumables/ Reagents market revenue (USD Million), by Europe
      • 4.2.7.3 Consumables/ Reagents market revenue (USD Million), by Asia Pacific
      • 4.2.7.4 Consumables/ Reagents market revenue (USD Million), by Latin America
      • 4.2.7.5 Consumables/ Reagents market revenue (USD Million), by Middle-East & Africa
  • 4.3 Services Market, 2014 to 2025
    • 4.3.1 Services market revenue (USD Million), by North America
    • 4.3.2 Services market revenue (USD Million), by Europe
    • 4.3.3 Services market revenue (USD Million), by Asia Pacific
    • 4.3.4 Services market revenue (USD Million), by Latin America
    • 4.3.5 Services market revenue (USD Million), by Middle-East & Africa
    • 4.3.6 Core genomic services, 2014 to 2025
      • 4.2.6.1 Core genomic services market revenue (USD Million), by North America
      • 4.2.6.2 Core genomic services market revenue (USD Million), by Europe
      • 4.2.6.3 Core genomic services market revenue (USD Million), by Asia Pacific
      • 4.2.6.4 Core genomic services market revenue (USD Million), by Latin America
      • 4.2.6.5 Core genomic services market revenue (USD Million), by Middle-East & Africa
    • 4.3.7 NGS based services, 2014 to 2025
      • 4.2.7.1 NGS based services market revenue (USD Million), by North America
      • 4.2.7.2 NGS based services market revenue (USD Million), by Europe
      • 4.2.7.3 NGS based services market revenue (USD Million), by Asia Pacific
      • 4.2.7.4 NGS based services market revenue (USD Million), by Latin America
      • 4.2.7.5 NGS based services market revenue (USD Million), by Middle-East & Africa
    • 4.3.8 Biomarker translation services, 2014 to 2025
      • 4.2.8.1 Biomarker translation services market revenue (USD Million), by North America
      • 4.2.8.2 Biomarker translation services market revenue (USD Million), by Europe
      • 4.2.8.3 Biomarker translation services market revenue (USD Million), by Asia Pacific
      • 4.2.8.4 Biomarker translation services market revenue (USD Million), by Latin America
      • 4.2.8.5 Biomarker translation services market revenue (USD Million), by Middle-East & Africa
    • 4.3.9 Computational services, 2014 to 2025
      • 4.2.9.1 Computational services market revenue (USD Million), by North America
      • 4.2.9.2 Computational services market revenue (USD Million), by Europe
      • 4.2.9.3 Computational services market revenue (USD Million), by Asia Pacific
      • 4.2.9.4 Computational services market revenue (USD Million), by Latin America
      • 4.2.9.5 Computational services market revenue (USD Million), by Middle-East & Africa
    • 4.3.10 Other services, 2014 to 2025
      • 4.2.10.1 Other services market revenue (USD Million), by North America
      • 4.2.10.2 Other services market revenue (USD Million), by Europe
      • 4.2.10.3 Other services market revenue (USD Million), by Asia Pacific
      • 4.2.10.4 Other services market revenue (USD Million), by Latin America
      • 4.2.10.5 Other services market revenue (USD Million), by Middle-East & Africa

Chapter 5 Genomics Market Categorization: Technology - Application Outlook

  • 5.1 Genomics Market Share By Technology - Application Outlook, 2014 To 2025
  • 5.2 Functional Genomics, 2014 to 2025
    • 5.2.1 Functional genomics market revenue (USD Million), by North America
    • 5.2.2 Functional genomics market revenue (USD Million), by Europe
    • 5.2.3 Functional genomics market revenue (USD Million), by Asia Pacific
    • 5.2.4 Functional genomics market revenue (USD Million), by Latin America
    • 5.2.5 Functional genomics market revenue (USD Million), by Middle-East & Africa
    • 5.2.6 Transfection, 2014 to 2025
      • 5.2.6.1 Transfection market revenue (USD Million), by North America
      • 5.2.6.2 Transfection market revenue (USD Million), by Europe
      • 5.2.6.3 Transfection market revenue (USD Million), by Asia Pacific
      • 5.2.6.4 Transfection market revenue (USD Million), by Latin America
      • 5.2.6.5 Transfection market revenue (USD Million), by Middle-East & Africa
    • 5.2.7 Real time PCR, 2014 to 2025
      • 5.2.7.1 Real time PCR market revenue (USD Million), by North America
      • 5.2.7.2 Real time PCR market revenue (USD Million), by Europe
      • 5.2.7.3 Real time PCR market revenue (USD Million), by Asia Pacific
      • 5.2.7.4 Real time PCR market revenue (USD Million), by Latin America
      • 5.2.7.5 Real time PCR market revenue (USD Million), by Middle-East & Africa
    • 5.2.8 RNA interference, 2014 to 2025
      • 5.2.8.1 RNA interference market revenue (USD Million), by North America
      • 5.2.8.2 RNA interference market revenue (USD Million), by Europe
      • 5.2.8.3 RNA interference market revenue (USD Million), by Asia Pacific
      • 5.2.8.4 RNA interference market revenue (USD Million), by Latin America
      • 5.2.8.5 RNA interference market revenue (USD Million), by Middle-East & Africa
    • 5.2.9 Mutational analysis, 2014 to 2025
      • 5.2.9.1 Mutational analysis market revenue (USD Million), by North America
      • 5.2.9.2 Mutational analysis market revenue (USD Million), by Europe
      • 5.2.9.3 Mutational analysis market revenue (USD Million), by Asia Pacific
      • 5.2.9.4 Mutational analysis market revenue (USD Million), by Latin America
      • 5.2.9.5 Mutational analysis market revenue (USD Million), by Middle-East & Africa
    • 5.2.10 SNP analysis, 2014 to 2025
      • 5.2.10.1 SNP analysis market revenue (USD Million), by North America
      • 5.2.10.2 SNP analysis market revenue (USD Million), by Europe
      • 5.2.10.3 SNP analysis market revenue (USD Million), by Asia Pacific
      • 5.2.10.4 SNP analysis market revenue (USD Million), by Latin America
      • 5.2.10.5 SNP analysis market revenue (USD Million), by Middle-East & Africa
    • 5.2.11 Microarray analysis, 2014 to 2025
      • 5.2.11.1 Microarray analysis market revenue (USD Million), by North America
      • 5.2.11.2 Microarray analysis market revenue (USD Million), by Europe
      • 5.2.11.3 Microarray analysis market revenue (USD Million), by Asia Pacific
      • 5.2.11.4 Microarray analysis market revenue (USD Million), by Latin America
      • 5.2.11.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
  • 5.3 Epigenetics, 2014 to 2025
    • 5.3.1 Epigenetics market revenue (USD Million), by North America
    • 5.3.2 Epigenetics market revenue (USD Million), by Europe
    • 5.3.3 Epigenetics market revenue (USD Million), by Asia Pacific
    • 5.3.4 Epigenetics market revenue (USD Million), by Latin America
    • 5.3.5 Epigenetics market revenue (USD Million), by Middle-East & Africa
    • 5.3.6 Bisulfite sequencing, 2014 to 2025
      • 5.3.6.1 Bisulfite sequencing market revenue (USD Million), by North America
      • 5.3.6.2 Bisulfite sequencing market revenue (USD Million), by Europe
      • 5.3.6.3 Bisulfite sequencing market revenue (USD Million), by Asia Pacific
      • 5.3.6.4 Bisulfite sequencing market revenue (USD Million), by Latin America
      • 5.3.6.5 Bisulfite sequencing market revenue (USD Million), by Middle-East & Africa
    • 5.3.7 Chromatin immunoprecipitation-sequencing (ChIP-Seq), 2014 to 2025
      • 5.3.7.1 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by North America
      • 5.3.7.2 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Europe
      • 5.3.7.3 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Asia Pacific
      • 5.3.7.4 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Latin America
      • 5.3.7.5 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Middle-East & Africa
    • 5.3.8 Methylated DNA immunoprecipitation (MeDIP), 2014 to 2025
      • 5.3.8.1 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by North America
      • 5.3.8.2 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Europe
      • 5.3.8.3 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Asia Pacific
      • 5.3.8.4 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Latin America
      • 5.3.8.5 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Middle-East & Africa
    • 5.3.9 High resolution melt, 2014 to 2025
      • 5.3.9.1 High resolution melt market revenue (USD Million), by North America
      • 5.3.9.2 High resolution melt market revenue (USD Million), by Europe
      • 5.3.9.3 High resolution melt market revenue (USD Million), by Asia Pacific
      • 5.3.9.4 High resolution melt market revenue (USD Million), by Latin America
      • 5.3.9.5 High resolution melt market revenue (USD Million), by Middle-East & Africa
    • 5.3.10 Chromatin accessibility assays, 2014 to 2025
      • 5.3.10.1 Chromatin accessibility assays market revenue (USD Million), by North America
      • 5.3.10.2 Chromatin accessibility assays market revenue (USD Million), by Europe
      • 5.3.10.3 Chromatin accessibility assays market revenue (USD Million), by Asia Pacific
      • 5.3.10.4 Chromatin accessibility assays market revenue (USD Million), by Latin America
      • 5.3.10.5 Chromatin accessibility assays market revenue (USD Million), by Middle-East & Africa
    • 5.3.11 Microarray analysis, 2014 to 2025
      • 5.3.11.1 Microarray analysis market revenue (USD Million), by North America
      • 5.3.11.2 Microarray analysis market revenue (USD Million), by Europe
      • 5.3.11.3 Microarray analysis market revenue (USD Million), by Asia Pacific
      • 5.3.11.4 Microarray analysis market revenue (USD Million), by Latin America
      • 5.3.11.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
  • 5.4 Pathway Analysis, 2014 to 2025
    • 5.4.1 Pathway analysis market revenue (USD Million), by North America
    • 5.4.2 Pathway analysis market revenue (USD Million), by Europe
    • 5.4.3 Pathway analysis market revenue (USD Million), by Asia Pacific
    • 5.4.4 Pathway analysis market revenue (USD Million), by Latin America
    • 5.4.5 Pathway analysis market revenue (USD Million), by Middle-East & Africa
    • 5.4.6 Bead-based analysis (Bio-Plex), 2014 to 2025
      • 5.4.6.1 Bead-based analysis (Bio-Plex) market revenue (USD Million), by North America
      • 5.4.6.2 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Europe
      • 5.4.6.3 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Asia Pacific
      • 5.4.6.4 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Latin America
      • 5.4.6.5 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Middle-East & Africa
    • 5.4.7 Microarray analysis, 2014 to 2025
      • 5.4.7.1 Microarray analysis market revenue (USD Million), by North America
      • 5.4.7.2 Microarray analysis market revenue (USD Million), by Europe
      • 5.4.7.3 Microarray analysis market revenue (USD Million), by Asia Pacific
      • 5.4.7.4 Microarray analysis market revenue (USD Million), by Latin America
      • 5.4.7.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
    • 5.4.8 Real time PCR, 2014 to 2025
      • 5.4.8.1 Real time PCR market revenue (USD Million), by North America
      • 5.4.8.2 Real time PCR market revenue (USD Million), by Europe
      • 5.4.8.3 Real time PCR market revenue (USD Million), by Asia Pacific
      • 5.4.8.4 Real time PCR market revenue (USD Million), by Latin America
      • 5.4.8.5 Real time PCR market revenue (USD Million), by Middle-East & Africa
    • 5.4.9 Proteomics tools (2-D PAGE; yeast 2-hybrid studies), 2014 to 2025
      • 5.4.9.1 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by North America
      • 5.4.9.2 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Europe
      • 5.4.9.3 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Asia Pacific
      • 5.4.9.4 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Latin America
      • 5.4.9.5 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Middle-East & Africa
  • 5.5 Biomarker Discovery, 2014 to 2025
    • 5.5.1 Biomarker Discovery market revenue (USD Million), by North America
    • 5.5.2 Biomarker Discovery market revenue (USD Million), by Europe
    • 5.5.3 Biomarker Discovery market revenue (USD Million), by Asia Pacific
    • 5.5.4 Biomarker Discovery market revenue (USD Million), by Latin America
    • 5.5.5 Biomarker Discovery market revenue (USD Million), by Middle-East & Africa
    • 5.5.6 Mass spectrometry, 2014 to 2025
      • 5.5.6.1 Mass spectrometry market revenue (USD Million), by North America
      • 5.5.6.2 Mass spectrometry market revenue (USD Million), by Europe
      • 5.5.6.3 Mass spectrometry market revenue (USD Million), by Asia Pacific
      • 5.5.6.4 Mass spectrometry market revenue (USD Million), by Latin America
      • 5.5.6.5 Mass spectrometry market revenue (USD Million), by Middle-East & Africa
    • 5.5.7 Real time PCR, 2014 to 2025
      • 5.5.7.1 Real time PCR market revenue (USD Million), by North America
      • 5.5.7.2 Real time PCR market revenue (USD Million), by Europe
      • 5.5.7.3 Real time PCR market revenue (USD Million), by Asia Pacific
      • 5.5.7.4 Real time PCR market revenue (USD Million), by Latin America
      • 5.5.7.5 Real time PCR market revenue (USD Million), by Middle-East & Africa
    • 5.5.8 Microarray analysis, 2014 to 2025
      • 5.5.8.1 Microarray analysis market revenue (USD Million), by North America
      • 5.5.8.2 Microarray analysis market revenue (USD Million), by Europe
      • 5.5.8.3 Microarray analysis market revenue (USD Million), by Asia Pacific
      • 5.5.8.4 Microarray analysis market revenue (USD Million), by Latin America
      • 5.2.8.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
    • 5.5.9 Statistical analysis, 2014 to 2025
      • 5.5.9.1 Statistical analysis market revenue (USD Million), by North America
      • 5.5.9.2 Statistical analysis market revenue (USD Million), by Europe
      • 5.5.9.3 Statistical analysis market revenue (USD Million), by Asia Pacific
      • 5.5.9.4 Statistical analysis market revenue (USD Million), by Latin America
      • 5.5.9.5 Statistical analysis market revenue (USD Million), by Middle-East & Africa
    • 5.5.10 Bioinformatics, 2014 to 2025
      • 5.5.10.1 Bioinformatics market revenue (USD Million), by North America
      • 5.5.10.2 Bioinformatics market revenue (USD Million), by Europe
      • 5.5.10.3 Bioinformatics market revenue (USD Million), by Asia Pacific
      • 5.5.10.4 Bioinformatics market revenue (USD Million), by Latin America
      • 5.5.10.5 Bioinformatics market revenue (USD Million), by Middle-East & Africa
    • 5.5.11 DNA sequencing, 2014 to 2025
      • 5.5.11.1 DNA sequencing market revenue (USD Million), by North America
      • 5.5.11.2 DNA sequencing market revenue (USD Million), by Europe
      • 5.5.11.3 DNA sequencing market revenue (USD Million), by Asia Pacific
      • 5.5.11.4 DNA sequencing market revenue (USD Million), by Latin America
      • 5.5.11.5 DNA sequencing market revenue (USD Million), by Middle-East & Africa
  • 5.6 Others, 2014 to 2025
    • 5.6.1 Others market revenue (USD Million), by North America
    • 5.6.2 Others market revenue (USD Million), by Europe
    • 5.6.3 Others market revenue (USD Million), by Asia Pacific
    • 5.6.4 Others market revenue (USD Million), by Latin America
    • 5.6.5 Others market revenue (USD Million), by Middle-East & Africa

Chapter 6 Genomics Market Categorization: End use Outlook

  • 6.1 Genomics Market Share by End use, 2014 to 2025
  • 6.2 Clinical & Research Laboratories, 2014 to 2025
    • 6.2.1 Clinical & research laboratories market revenue (USD Million), by North America
    • 6.2.2 Clinical & research laboratories market revenue (USD Million), by Europe
    • 6.2.3 Clinical & research laboratories market revenue (USD Million), by Asia Pacific
    • 6.2.4 Clinical & research laboratories market revenue (USD Million), by Latin America
    • 6.2.5 Clinical & research laboratories market revenue (USD Million), by Middle-East & Africa
  • 6.3 Academic and Government Institutes, 2014 to 2025
    • 6.3.1 Academic & government institutes market revenue (USD Million), by North America
    • 6.3.2 Academic & government institutes market revenue (USD Million), by Europe
    • 6.3.3 Academic & government institutes market revenue (USD Million), by Asia Pacific
    • 6.3.4 Academic & government institutes market revenue (USD Million), by Latin America
    • 6.3.5 Academic & government institutes market revenue (USD Million), by Middle-East & Africa
  • 6.4 Hospitals and Clinics, 2014 to 2025
    • 6.4.1 Hospitals & clinics market revenue (USD Million), by North America
    • 6.4.2 Hospitals & clinics market revenue (USD Million), by Europe
    • 6.4.3 Hospitals & clinics market revenue (USD Million), by Asia Pacific
    • 6.4.4 Hospitals & clinics market revenue (USD Million), by Latin America
    • 6.4.5 Hospitals & clinics market revenue (USD Million), by Middle-East & Africa
  • 6.5 Pharmaceutical and Biotechnology Companies, 2014 to 2025
    • 6.5.1 Pharmaceutical & biotechnology companies market revenue (USD Million), by North America
    • 6.5.2 Pharmaceutical & biotechnology companies market revenue (USD Million), by Europe
    • 6.5.3 Pharmaceutical & biotechnology companies market revenue (USD Million), by Asia Pacific
    • 6.5.4 Pharmaceutical & biotechnology companies market revenue (USD Million), by Latin America
    • 6.5.5 Pharmaceutical & biotechnology companies market revenue (USD Million), by Middle-East & Africa
  • 6.6 Other End Users, 2014 to 2025
    • 6.6.1 Other end users market revenue (USD Million), by North America
    • 6.6.2 Other end users market revenue (USD Million), by Europe
    • 6.6.3 Other end users market revenue (USD Million), by Asia Pacific
    • 6.6.4 Other end users market revenue (USD Million), by Latin America
    • 6.6.5 Other end users market revenue (USD Million), by Middle-East & Africa

Chapter 7 Genomics Market Categorization: Regional Outlook

  • 7.1 Genomics Market Share By Region, 2014 to 2025
  • 7.2 North America
    • 7.2.1 Genomics market revenue, (USD million), by U.S.
    • 7.2.2 Genomics market revenue, (USD million), by Canada
    • 7.2.3 U.S.
      • 7.2.3.1 Genomics market, by deliverables
      • 7.2.3.2 Genomics market, by application & technology
      • 7.2.3.3 Genomics market, by end use
    • 7.2.4 Canada
      • 7.2.4.1 Genomics market, by deliverables
      • 7.2.4.2 Genomics market, by application & technology
      • 7.2.4.3 Genomics market, by end use
  • 7.3 Europe
    • 7.3.1 Genomics market revenue, (USD million), by Germany
    • 7.3.2 Genomics market revenue, (USD million), by U.K.
    • 7.3.3 Germany
      • 7.3.3.1 Genomics market, by deliverables
      • 7.3.3.2 Genomics market, by application & technology
      • 7.3.3.3 Genomics market, by end use
    • 7.3.4 U.K.
      • 7.3.4.1 Genomics market, by deliverables
      • 7.3.4.2 Genomics market, by application & technology
      • 7.3.4.3 Genomics market, by end use
  • 7.4 Asia Pacific
    • 7.4.1 Genomics market revenue, (USD million), by Germany
    • 7.4.2 Genomics market revenue, (USD million), by U.K.
    • 7.4.3 Japan
      • 7.4.3.1 Genomics market, by deliverables
      • 7.4.3.2 Genomics market, by application & technology
      • 7.4.3.3 Genomics market, by end use
    • 7.4.4 China
      • 7.4.4.1 Genomics market, by deliverables
      • 7.4.4.2 Genomics market, by application & technology
      • 7.4.4.3 Genomics market, by end use
  • 7.5 Latin America
    • 7.5.1 Genomics market revenue, (USD million), by Brazil
    • 7.5.2 Brazil
      • 7.5.2.1 Genomics market, by deliverables
      • 7.5.2.2 Genomics market, by application & technology
      • 7.5.2.3 Genomics market, by end use
  • 7.6 MEA
    • 7.6.1 Genomics market revenue, (USD million), by MEA
    • 7.6.2 South Africa
      • 7.6.2.1 Genomics market, by deliverables
      • 7.6.2.2 Genomics market, by application & technology
      • 7.6.2.3 Genomics market, by end use

List of Tables

  • TABLE 1 Gene discoveries and its application in personalized treatment for neurologic diseases
  • TABLE 2 North America genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 3 North America genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 4 North America genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 5 North America genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 6 North America functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 7 North America epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 8 North America pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 9 North America biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 11 U.S. genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 12 U.S. genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 13 U.S. genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 14 U.S. functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 15 U.S. epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 16 U.S. pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 17 U.S. biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 18 Canada genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 19 Canada genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 20 Canada genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 21 Canada genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 22 Canada functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 23 Canada epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 24 Canada pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 25 Canada biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 26 Europe genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 27 Europe genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 28 Europe genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 29 Europe genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 30 Europe functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 31 Europe epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 32 Europe pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 33 Europe biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 34 Germany genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 35 Germany genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 36 Germany genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 37 Germany genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 38 Germany functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 39 Germany epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 40 Germany pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 41 Germany biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 42 U.K. genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 43 U.K. genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 44 U.K. genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 45 U.K. genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 46 U.K. functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 47 U.K. epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 48 U.K. pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 49 U.K. biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 50 Asia Pacific genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 51 Asia Pacific genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 52 Asia Pacific genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 53 Asia Pacific genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 54 Asia Pacific functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 55 Asia Pacific epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 56 Asia Pacific pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 57 Asia Pacific biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 58 Japan genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 59 Japan genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 60 Japan genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 61 Japan genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 62 Japan functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 63 Japan epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 64 Japan pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 65 Japan biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 66 China genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 67 China genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 68 China genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 69 China genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 70 China functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 71 China epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 72 China pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 73 China biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 74 Latin America genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 75 Latin America genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 76 Latin America genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 77 Latin America genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 78 Latin America functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 79 Latin America epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 80 Latin America pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 81 Latin America biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 82 Brazil genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 83 Brazil genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 84 Brazil genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 85 Brazil genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 86 Brazil functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 87 Brazil epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 88 Brazil pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 89 Brazil biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 90 MEA genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 91 MEA genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 92 MEA genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 93 MEA genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 94 MEA functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 95 MEA epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 96 MEA pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 97 MEA biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 98 South Africa genomics market estimates & forecasts, by deliverables, 2014 - 2025 (USD Million)
  • TABLE 99 South Africa genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
  • TABLE 100 South Africa genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
  • TABLE 101 South Africa genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 102 South Africa functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 103 South Africa epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 104 South Africa pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 105 South Africa biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Application of human genome to personal healthcare
  • FIG. 12 Spinal muscular atrophy (SMA) prenatal screening trend in the department of defence from 2016 to July 2017
  • FIG. 13 Categories of tests offered by Direct-To-Consumer (DTC) companies
  • FIG. 14 Global impact of biotech crop adoption in 2014
  • FIG. 15 Market restraint relevance analysis (Current & future impact)
  • FIG. 16 Penetration & growth prospect mapping for Technology, 2018
  • FIG. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 18 Porter's Five Forces Analysis
  • FIG. 19 Genomics market: Product outlook key takeaways
  • FIG. 20 Global genomics market: Product movement analysis
  • FIG. 21 Global genomics instruments/systems market, 2014 - 2025 (USD Million)
  • FIG. 22 Global genomics consumables/reagents market, 2014 - 2025 (USD Million)
  • FIG. 23 Global genomics services market, 2014 - 2025 (USD Million)
  • FIG. 24 Global core genomics services market, 2014 - 2025 (USD Million)
  • FIG. 25 Global NGS based services market, 2014 - 2025 (USD Million)
  • FIG. 26 Global biomarker translation services market, 2014 - 2025 (USD Million)
  • FIG. 27 Global computational services market, 2014 - 2025 (USD Million)
  • FIG. 28 Global other services market, 2014 - 2025 (USD Million)
  • FIG. 29 Genomics market: Technology - Application outlook key takeaways
  • FIG. 30 Global genomics market: Technology - application movement analysis
  • FIG. 31 Global functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 32 Global transfection in functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 33 Global real time PCR in functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 34 Global RNA interference in functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 35 Global mutational analysis in functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 36 Global SNP analysis in functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 37 Global microarray analysis in functional genomics market, 2014 - 2025 (USD Million)
  • FIG. 38 Global epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 39 Global bisulfite sequencing in epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 40 Global chromatin immunoprecipitation-sequencing in epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 41 Global methylated DNA immunoprecipitation in epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 42 Global high resolution melt in epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 43 Global chromatin accessibility assays in epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 44 Global microarray analysis in epigenetics market, 2014 - 2025 (USD Million)
  • FIG. 45 Global pathway analysis market, 2014 - 2025 (USD Million)
  • FIG. 46 Global luminex bead-based analysis (Bio-Plex) for pathway analysis market, 2014 - 2025 (USD Million)
  • FIG. 47 Global microarray analysis in pathway analysis market, 2014 - 2025 (USD Million)
  • FIG. 48 Global real time PCR in pathway analysis market, 2014 - 2025 (USD Million)
  • FIG. 49 Global proteomics tools (2-D PAGE; yeast 2-hybrid studies) in pathway analysis market, 2014 - 2025 (USD Million)
  • FIG. 50 Global biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 51 Global mass spectrometry for biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 52 Global real time PCR for biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 53 Global microarray analysis for biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 54 Global statistical analysis for biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 55 Global bioinformatics for biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 56 Global DNA sequencing for biomarker discovery market, 2014 - 2025 (USD Million)
  • FIG. 57 Global other services market, 2014 - 2025 (USD Million)
  • FIG. 58 Genomics market: End use outlook key takeaways
  • FIG. 59 Global genomics market: End use movement analysis
  • FIG. 60 Global clinical & research laboratories market, 2014 - 2025 (USD Million)
  • FIG. 61 Global academic and government institutes market, 2014 - 2025 (USD Million)
  • FIG. 62 Global hospital and clinics market, 2014 - 2025 (USD Million)
  • FIG. 63 Global pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
  • FIG. 64 Global other end users market, 2014 - 2025 (USD Million)
  • FIG. 65 Regional market place: Key takeaway
  • FIG. 66 Genomics regional outlook, 2018 & 2025
  • FIG. 67 North America genomics market, 2014 - 2025 (USD Million)
  • FIG. 68 U.S genomics market, 2014 - 2025 (USD Million)
  • FIG. 69 Canada genomics market, 2014 - 2025 (USD Million)
  • FIG. 70 Europe genomics market, 2014 - 2025 (USD Million)
  • FIG. 71 Germany genomics market, 2014 - 2025 (USD Million)
  • FIG. 72 U.K. genomics market, 2014 - 2025 (USD Million)
  • FIG. 73 Asia Pacific genomics market, 2014 - 2025 (USD Million)
  • FIG. 74 Japan genomics market, 2014 - 2025 (USD Million)
  • FIG. 75 China genomics market, 2014 - 2025 (USD Million)
  • FIG. 76 Latin America genomics market, 2014 - 2025 (USD Million)
  • FIG. 77 Brazil genomics market, 2014 - 2025 (USD Million)
  • FIG. 78 MEA genomics market, 2014 - 2025 (USD Million)
  • FIG. 79 South Africa genomics market, 2014 - 2025 (USD Million)
  • FIG. 80 Strategy framework
  • FIG. 81 Participant categorization
Back to Top